Active Ingredient: DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
Proprietary Name: ALYFTREK
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 125MG;50MG;EQ 10MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N218730
Product Number: 002
Approval Date: Dec 20, 2024
Applicant Holder Full Name: VERTEX PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
